Cellosaurus logo
expasy logo

Cellosaurus K562 Dox (CVCL_E6HY)

[Text version]
Cell line name K562 Dox
Synonyms K562-Dox; K562/DOX; K562/Dox
Accession CVCL_E6HY
Resource Identification Initiative To cite this cell line use: K562 Dox (RRID:CVCL_E6HY)
Comments From: Ashman, Leonie K.; University of Newcastle; Adelaide; Australia.
Population: Caucasian.
Characteristics: Stably overexpresses ABCB1 (PubMed=21718141).
Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
Sequence variations
  • Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 14 fused to ABL1 exon 2 (b3a2 transcript) (from parent cell line).
  • Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
Disease Blast phase chronic myelogenous leukemia, BCR-ABL1 positive (NCIt: C9110)
Chronic myeloid leukemia (ORDO: Orphanet_521)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_0004 (K-562)
Children:
CVCL_E6HZ (K562 Dox DAS)CVCL_E6I0 (K562 Dox IM1)CVCL_E6I1 (K562 Dox IM2)
CVCL_E6I2 (K562 Dox IM3)CVCL_E6IE (K562 Dox #5 NIL)CVCL_E6IF (K562 Dox #8 NIL)
Sex of cell Female
Age at sampling 53Y
Category Cancer cell line
Publications

PubMed=21718141; DOI=10.3109/10428194.2011.591013
Tang C., Schafranek L., Watkins D.B., Parker W.T., Moore S., Prime J.A., White D.L., Hughes T.P.
Tyrosine kinase inhibitor resistance in chronic myeloid leukemia cell lines: investigating resistance pathways.
Leuk. Lymphoma 52:2139-2147(2011)

PubMed=27536777; DOI=10.1371/journal.pone.0161470; PMCID=PMC4990177
Eadie L.N., Hughes T.P., White D.L.
ABCB1 overexpression is a key initiator of resistance to tyrosine kinase inhibitors in CML cell lines.
PLoS ONE 11:e0161470.1-e0161470.18(2016)

Entry history
Entry creation10-Apr-2025
Last entry update10-Apr-2025
Version number1